About Barash Law, Pharmaceutical Patent Attorney for Life Sciences
A focused practice for pharmaceutical innovators
Barash Law was founded to give life science innovators an IP partner who understands both the science and the business side of pharmaceutical and biotech development. Having worked in-house for emerging innovators, Barash Law possesses a unique skill set combining regulatory, IP, and contract negotiation and skills for supporting and advising our client partners.
Eyal Barash
Eyal Barash is a patent attorney with deep roots in chemistry and nearly two decades advising life science companies. His background includes significant experience in solid-state chemistry and solid form patents, along with early work applying AI and machine learning to drug discovery. That mix of technical fluency and legal judgment helps teams navigate decisions on what to claim, when to file, and how to integrate IP with development and regulatory plans.
How we work with pharma teams and investors
Startups, clinical-stage companies, and investor-backed ventures engage Barash Law as outside in-house counsel or for targeted projects. We join R&D discussions, review screening data, and map IP to near-term objectives. For leaders balancing budgets and timelines, our guidance prioritizes IP that matters.
Solid form expertise clients can rely on
When it’s time to claim a polymorph, salt, cocrystal, or amorphous form, experience counts. Barash Law has long worked in this niche, helping clients convert solid form screening results into strong patents. Teams use this capability to support exclusivity and strengthen negotiations with partners.
Patent drafting and prosecution with substance
Applications are crafted to capture real value: claims that read on commercially capable embodiments, specifications that support enforceability, and strategies that anticipate examiner concerns. We handle Office Actions, examiner interviews, continuations, and international coordination so your portfolio develops on schedule.
Education, publishing, and speaking
Barash Law contributes to the industry through
written insights and
frequent speaking. Expect practical commentary on pharmaceutical patent strategy, solid form developments, and policy changes that matter to drug developers. This education-first approach reflects our belief that informed teams make better IP decisions.
Ready to align IP with your roadmap?
If you need portfolio counsel for a new program, a plan for solid form patents, or a focused approach to prosecution, we’re here to help. Barash Law brings pharmaceutical depth, clear communication, and practical strategy to your IP.